Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 335 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

335 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 335 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

335 programs

Clinical programs

Page 2 of 7

  1. CINRYZE with rHuPH20

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 mab completed

    1 trial

  2. CUVITRU - Ig subcutaneous human 20%

    Takeda

    COPD Exacerbation Acute

    phase 2 mab active

    1 trial

  3. CX501

    Takeda

    EPIDERMOLYSIS BULLOSA

    phase 2 small molecule completed

    1 trial

  4. Cabozantinib

    Takeda

    Advanced Renal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  5. Cabozantinib

    Takeda

    Advanced Hepatocellular Carcinoma

    phase 2 small molecule completed

    1 trial

  6. Celaderm (Frozen Cultured Epidermal Allograft)

    Takeda

    Leg Ulcer

    phase 2 other completed

    1 trial

  7. Clarithromycin

    Takeda

    Myeloma

    phase 2 small molecule active

    1 trial

  8. Colchicine, 0.6 mg PO BID

    Takeda

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

  9. Cx611

    Takeda

    Bacterial Pneumonia

    phase 2 mab completed

    1 trial

  10. Cyclophosphamide

    Takeda

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

    phase 2 small molecule active

    1 trial

  11. Cyclophosphamide

    Takeda

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  12. DX-88 (ecallantide)

    Takeda

    Hereditary Angioedema (HAE)

    phase 2 small molecule completed

    1 trial

  13. Danavorexton

    Takeda

    Sleep Apnea

    phase 2 small molecule completed

    2 trials

  14. Dasatinib

    Takeda

    Acute Lymphoblastic Leukemia

    phase 2 small molecule terminated

    1 trial

  15. Dazostinag

    Takeda

    Solid Neoplasms

    phase 2 small molecule completed

    1 trial

  16. Dexlansoprazole

    Takeda

    Barrett's Esophagus

    phase 2 small molecule terminated

    1 trial

  17. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease (GERD)

    phase 2 small molecule active

    1 trial

  18. Docetaxel

    Takeda

    Non-small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  19. Elritercept

    Takeda

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  20. Elritercept

    Takeda

    Myelodysplastic Syndromes

    phase 2 small molecule active

    2 trials

  21. Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Ulcerative Colitis or Crohn's Disease

    phase 2 small molecule active

    1 trial

  22. Everolimus

    Takeda

    Clear-cell Metastatic Renal Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  23. FST-100

    Takeda

    Acute Viral Conjunctivitis

    phase 2 small molecule completed

    1 trial

  24. FST-100

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 small molecule completed

    1 trial

  25. FST-100 Ophthalmic Suspension

    Takeda

    Acute Adenoviral Conjunctivitis

    phase 2 small molecule terminated

    1 trial

  26. Fasiglifam

    Takeda

    Type 2 Diabetes Mellitus

    phase 2 small molecule terminated

    2 trials

  27. Febuxostat

    Takeda

    Joint Damage

    phase 2 small molecule completed

    1 trial

  28. Febuxostat

    Takeda

    Angina

    phase 2 small molecule terminated

    1 trial

  29. Febuxostat

    Takeda

    Renal Impairment

    phase 2 small molecule completed

    1 trial

  30. Febuxostat

    Takeda

    Hyperuricosuria

    phase 2 small molecule completed

    1 trial

  31. Febuxostat

    Takeda

    Hypertension

    phase 2 small molecule completed

    1 trial

  32. Fruquintinib Combined With Chemotherapy

    Takeda

    Metastatic Colorectal Cancer (CRC)

    phase 2 small molecule active

    1 trial

  33. GA-GCB

    Takeda

    Gaucher Disease

    phase 2 small molecule completed

    1 trial

  34. GDX012

    Takeda

    Leukemia

    phase 2 small molecule terminated

    1 trial

  35. GI.1/GII.4 (15/15)

    Takeda

    Norovirus

    phase 2 mab completed

    1 trial

  36. HGT-1110

    Takeda

    Metachromatic Leukodystrophy (MLD)

    phase 2 mab completed

    1 trial

  37. HGT-1111

    Takeda

    Late Infantile Metachromatic Leukodystrophy

    phase 2 small molecule terminated

    1 trial

  38. HGT-1410

    Takeda

    Sanfilippo Syndrome

    phase 2 small molecule terminated

    1 trial

  39. Hepatitis A Vaccine

    Takeda

    Healthy Volunteers

    phase 2 mab completed

    1 trial

  40. IXAZOMIB

    Takeda

    Follicular Lymphoma

    phase 2 small molecule completed

    1 trial

  41. Idursulfase IT (1 mg)

    Takeda

    Hunter Syndrome

    phase 2 small molecule completed

    1 trial

  42. Ilaprazole

    Takeda

    Esophagitis

    phase 2 small molecule completed

    1 trial

  43. Immune Globulin Infusion (Human), 10% Solution

    Takeda

    Hematologic Malignancies

    phase 2 mab active

    1 trial

  44. Ixazomib

    Takeda

    ALL, Childhood

    phase 2 small molecule active

    1 trial

  45. Ixazomib

    Takeda

    Mantle Cell Lymphoma

    phase 2 small molecule active

    2 trials

  46. Ixazomib

    Takeda

    Multiple Myeloma

    phase 2 small molecule completed

    15 trials

  47. Ixazomib

    Takeda

    Myeloid Hematologic Malignancy

    phase 2 small molecule completed

    1 trial

  48. Ixazomib

    Takeda

    Leukemia

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

335 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.